Evidence supporting the use of: N-acetylcysteine
For the health condition: Heavy Metal Poisoning

Links: Go back one page, Tool main page, Ingredients list, Health conditions list, Body systems list

Synopsis

Source of validity: Scientific
Rating (out of 5): 2

N-acetylcysteine (NAC) is primarily recognized as a precursor to glutathione, a major endogenous antioxidant and cellular detoxifier. Its use in heavy metal poisoning is supported by mechanistic and some preclinical studies, but robust clinical evidence in humans is limited. NAC’s theoretical benefit lies in its ability to increase intracellular glutathione, which can bind and help detoxify certain heavy metals (such as mercury, lead, and cadmium), reducing oxidative stress and facilitating excretion. Animal studies and in vitro experiments have shown that NAC administration can mitigate oxidative damage and tissue injury associated with heavy metal exposure. For example, rodent models exposed to mercury or lead and treated with NAC showed reduced markers of oxidative stress and, in some cases, lower tissue metal concentrations. However, clinical studies in humans are scarce and mostly limited to case reports or small trials; no large-scale randomized controlled trials have established its efficacy compared to standard chelation agents like dimercaprol or EDTA. As such, while there is a scientific rationale and some experimental evidence for NAC’s supportive role in heavy metal detoxification—primarily as an adjunct to conventional therapy—its routine use in human heavy metal poisoning is not widely endorsed by clinical guidelines. The evidence supporting its use rates as weak to moderate (2/5), mostly based on mechanistic plausibility and animal data rather than extensive human clinical trials.

More about N-acetylcysteine
More about Heavy Metal Poisoning

Products containing N-acetylcysteine

We currently have no products on Vitabase that contain this ingredient.